{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:37:01Z","timestamp":1769578621000,"version":"3.49.0"},"reference-count":51,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2022,3,4]]},"DOI":"10.1080\/14740338.2021.1979958","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T12:13:28Z","timestamp":1631621608000},"page":"363-371","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Monitoring and safety of CAR-T therapy in clinical practice"],"prefix":"10.1080","volume":"21","author":[{"given":"Jos\u00e9 M.","family":"Serra L\u00f3pez-Matencio","sequence":"first","affiliation":[{"name":"Hospital Pharmacy Department, Hospital Universitario de La Princesa, IIS-P, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valle","family":"G\u00f3mez Garcia de Soria","sequence":"additional","affiliation":[{"name":"Haematology Department, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"G\u00f3mez","sequence":"additional","affiliation":[{"name":"Methodology Unit, Health Research Institute Princesa (IIS-IP), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estefan\u00eda","family":"Ala\u00f1\u00f3n-Plaza","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy Department, Hospital Universitario de La Princesa, IIS-P, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Mu\u00f1oz-Calleja","sequence":"additional","affiliation":[{"name":"Immunology Department, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain"},{"name":"Catedra UAM-Roche, EPID-Future, Medicine Department, Universidad Aut\u00f3noma de Madrid (UAM), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0813101106"},{"key":"cit0002","unstructured":"Yescarta: EPAR \u2013 risk-management-plan summary. European Medicines Agency; 2018. [cited 2021 Jul 10]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/rmp-summary\/yescarta-epar-risk-management-plan-summary_en.pdf."},{"key":"cit0003","unstructured":"Kymriah: EPAR \u2013 risk-management-plan summary. European Medicines Agency; 2018. [cited 2021 Jul 10]. Available from https:\/\/www.ema.europa.eu\/en\/documents\/rmp-summary\/kymriah-epar-risk-management-plan-summary_en.pdf."},{"key":"cit0004","unstructured":"Lisocabtagene maraleucel package insert. [cited 2021 Jul 10]. Available from: https:\/\/www.fda.gov\/media\/145711\/download."},{"key":"cit0005","unstructured":"Idecabtagene vicleucel package insert. [cited 2021 Jul 10].\u00a0Available from: https:\/\/www.fda.gov\/media\/147055\/download."},{"key":"cit0006","unstructured":"Brexucabtagene autoleucel package insert. [cited 2021 Jul 10]. Available from: https:\/\/www.fda.gov\/media\/140409\/download."},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa4967"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-018-2436-z"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6711"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2678"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2015.03.011"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0487-3"},{"key":"cit0015","first-page":"1","volume":"56","author":"Shimabukuro-Vornhagen A","year":"2018","journal-title":"J Immunother Cancer"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0036-4"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-485623"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25951"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-703751"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-552729"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2017.09.002"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0451-2"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0239-0"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1038\/mto.2016.11"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002592"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-793760"},{"key":"cit0027","unstructured":"Tocilizumab summary of product characteristics. [cited 2021 Mar 15]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/roactemra-epar-product-information_en.pdf."},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1084"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.2147\/AHMT.S109495"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1319"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-019-0580-3"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.19"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30864-7"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0280-y"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.148"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000035"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-12-893396"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001463"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008226"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-115252"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-126218"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02079"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-124177"},{"issue":"1","key":"cit0046","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.clml.2019.07.190","volume":"19","author":"Pasquini M","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-130983"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1080\/14653240310002298"},{"key":"cit0049","volume-title":"Foundation for the Accreditation of Cellular Therapy (FACT) -Joint Accreditation Committee ISCT\/EBMT (JACIE)","author":"Hematopoietic Cellular Therapy Accreditation Manual","year":"2018"},{"key":"cit0050","volume-title":"Foundation for the Accreditation of Cellular Therapy (FACT)","author":"Immune Effector Cells Accreditation Manual","year":"2018","edition":"1"},{"issue":"3","key":"cit0051","first-page":"18","volume":"15","author":"Brown MA","year":"2018","journal-title":"HOPA News"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2021.1979958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T14:18:25Z","timestamp":1646403505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2021.1979958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,4]]}},"alternative-id":["10.1080\/14740338.2021.1979958"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2021.1979958","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}